Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
BPC-157 has a favorable acute safety signal in animal studies, but there are zero completed Phase III human clinical trials, so its human side-effect profile is essentially uncharacterized
Looking forward to my second month
You take certain medications
If you take insulin or sulfonylureas, your provider may need to reduce those doses to prevent low blood sugar
The compound did not appear to affect food intake, behavior, or general health status in treated animals
US$ 22.68
US$ 27.51
US$ 28.40
US$ 28.79
US$ 20.63
US$ 27.75
US$ 23.29
